about
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencingBacillus subtilis cell cycle as studied by fluorescence microscopy: constancy of cell length at initiation of DNA replication and evidence for active nucleoid partitioning.Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection SComparative genomics suggests that the human pathogenic fungus Pneumocystis jirovecii acquired obligate biotrophy through gene lossGenomic insights into the fungal pathogens of the genus pneumocystis: obligate biotrophs of humans and other mammals.Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumoniaComparative genomics suggests primary homothallism of Pneumocystis species.Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.Functional characterization of the Pneumocystis jirovecii potential drug targets dhfs and abz2 involved in folate biosynthesisStrain typing methods and molecular epidemiology of Pneumocystis pneumoniaMolecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients.Functional characterization of Pneumocystis carinii brl1 by transspecies complementation analysis.De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient.Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.Genome sequencing of the plant pathogen Taphrina deformans, the causal agent of peach leaf curl.Functional differentiation of tbf1 orthologues in fission and budding yeasts.Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.Identification and Functional Ascertainment of the Pneumocystis jirovecii Potential Drug Targets Gsc1 and Kre6 Involved in Glucan Synthesis.Genetic analysis of the flaA locus of Bacillus subtilis.Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil.Typing methods to approach Pneumocystis carinii genetic heterogeneity.Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.Effective treatment of invasive Aspergillus fumigatus infection using combinations of topical and systemic antifungals in a severely burned patient.β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.Choice of an adequate promoter for efficient complementation in Saccharomyces cerevisiae: a case study.Isolation of the Pneumocystis carinii dihydrofolate synthase gene and functional complementation in Saccharomyces cerevisiae.Potential coinfections complicate typing of Pneumocystis carinii f. sp. hominisHypothetical Pneumocystis jirovecii transmission from immunocompetent carriers to infant.A method for the determination of bacterial spore DNA content based on isotopic labelling, spore germination and diphenylamine assay; ploidy of spores of several Bacillus species.Development of a molecular typing method for Pneumocystis carinii sp.f. hominis.Poor value of pulsed-field gel electrophoresis to investigate long-term scale epidemiology of methicillin-resistant Staphylococcus aureus.Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.Pneumocystis jirovecii dihydrofolate reductase polymorphisms associated with failure of prophylaxis.The development of a typing method for an uncultivable microorganism: the example of Pneumocystis jirovecii.Pneumocystis jirovecii genotypes involved in pneumocystis pneumonia outbreaks among renal transplant recipients.Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis.Mechanisms of Surface Antigenic Variation in the Human Pathogenic Fungus Pneumocystis jirovecii.
P50
Q30248345-F5B98D7E-0CC6-4765-883F-62E7362CAA84Q31152913-A0AC0C85-D34D-4281-B8DB-A7606302373FQ33723637-439CBE97-AC7B-4531-9C4C-2629B1EB00C2Q33909379-195E6945-F779-4AC6-BDA9-1533C2D59FB1Q34154706-ACD1D662-F6A2-4F56-BE1E-B9566532F212Q34466417-EFCFA2CE-3495-46F5-93FA-A7FA55E0E21BQ34502836-F8C2D4AB-633A-4230-81F3-80CD08D6FCB2Q35038258-3BCB02A0-FF15-46BD-9247-3B7064A859DAQ35066605-21676D0D-F2F3-4DB0-9B90-8E83542BFE27Q35385810-9B962985-CF3E-4E67-95EE-08F4F7B16622Q35880718-695A7DB0-F306-4FCE-B2AD-E83D6231FDAEQ35880726-3F46A3DC-67CF-41D8-85AD-5D1776BAFAC7Q36313724-0BF37263-7B48-4B8D-8B0A-8D59796F1A30Q36492975-35744074-E656-43EC-A338-39201A7B8E6DQ36570827-9EF4E7A9-96B5-4A86-9242-AD4F828D502DQ36829211-DE55FCA9-3DE8-4CF7-9270-4D03450D4850Q37099398-B70B0C5B-A8CB-4E97-B44D-76CA646D6B37Q37598743-F235AFCC-5CF8-4328-AC36-2F8275802C7FQ38934525-C9BD9AFF-DEC7-4FE4-9F5A-A2BEF1652BFEQ38953280-4F271183-FF03-43E5-9D4E-070B593559DBQ39177044-A99CC80B-DD1E-4762-8F86-56D10766EC83Q39941860-E1C80CC9-CB09-4FA2-AFC8-C9CCFC200082Q40358605-DC0FD840-6FF9-46AB-9C0F-96C10E3BBD7EQ40837958-94B8CAC2-F6AB-43FB-B834-8F1003156DA7Q41542809-069E5F53-A22B-4F74-83CC-CA8A47B44C1FQ42201729-136639A6-9136-475F-B4B1-818D07321E38Q42258343-A4422302-FAEE-4E1F-9A79-DD45EBB202D7Q42627179-497C1B5B-FC40-4F83-B4D1-44099D85D5BEQ42681138-8C55945A-D41A-4EBE-AE51-8402632F9C33Q42742637-5C01BCEB-FB20-41E7-A178-1D34CC927B83Q43129000-3F340298-3B3A-4EC3-8B7E-6B7E7D84655BQ43467085-18282E7B-609A-4EE4-9A3E-6E1DBF9E8265Q43847065-B9DFCA1E-9241-4BAC-AE91-EED510E4E20AQ44472365-2B5ADA3F-D44D-4496-B47D-D520326206B7Q44598922-8BB33CDE-5DC6-4646-A806-E56E610D2B74Q44736817-2A15CC27-107C-4DF7-94E9-6FDD1AE3F909Q45053722-8FB20CEB-5CE0-4691-9FAE-2C7C1EC71892Q45912774-EF85243A-6C84-4314-949A-1CB4371FEB7FQ45950902-BAC6D3D7-608D-4733-A525-E8B5EE5425BFQ47097269-023F5A8D-5902-4B8F-B991-FF56E6176065
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philippe M Hauser
@ast
Philippe M Hauser
@en
Philippe M Hauser
@es
Philippe M Hauser
@nl
Philippe M Hauser
@sl
type
label
Philippe M Hauser
@ast
Philippe M Hauser
@en
Philippe M Hauser
@es
Philippe M Hauser
@nl
Philippe M Hauser
@sl
prefLabel
Philippe M Hauser
@ast
Philippe M Hauser
@en
Philippe M Hauser
@es
Philippe M Hauser
@nl
Philippe M Hauser
@sl
P106
P21
P31
P496
0000-0003-2834-7922